High-affinity [3H]folate binding in solubilized human choroid plexus homogenate displayed characteristics, e.g. apparent positive co-operativity, which are typical of specific folate binding. The highest folate-binding activity per g of protein was associated with the 27000 g membrane pellet where the membrane-marker enzyme y-glutamyltransferase had its main localization. Ultrogel AcA 44 chromatography revealed two major folate-binding proteins (molecular masses > 110 kDa and approx. 100 kDa) and one minor one (molecular mass approx. 25 kDa) in the Triton X-100-solubilized membrane pellet. After exposure of the membrane pellet to phosphatidylinositol-specific phospholipase C there was only one large 25 kDa peak of folate binding. This could suggest that the folate-binding protein is anchored to the membrane by a glycosylphosphatidylinositol moiety, which can be inserted into Triton X-100 micelles and thus can give rise to forms of large molecular size on gel filtration. This notion was supported by the identical molecular masses of the > 110 kDa and 25 kDa folate-binding peaks determined by SDS/PAGE and immunoblotting. The folate-binding protein in choroid plexus cross-reacted with rabbit antibodies against the 25 kDa human milk folate-binding protein, and paraffin-embedded sections of choroid plexus showed immunostaining after exposure to rabbit anti-(human milk folate-binding protein) serum (1: 8000 dilution).
INTRODUCTION
Choroid plexus, the anatomical locus of the blood-cerebrospinal fluid barrier, plays an important role in transport and homoeostasis of vitamins and micronutrients in the central nervous system (Spector, 1977a (Spector, , 1989 . Folates are present in the cerebrospinal fluid and brain of mammals at higher concentrations than in plasma (Spector, 1989) . Folates must therefore enter the cerebrospinal fluid/brain from the blood since they are not synthesized in mammalian tissues. It has been suggested that a mechanism for transfer of folates from blood into the cerebrospinal fluid might reside in the choroid plexus (Spector, 1977a (Spector, , 1989 .
A folate-binding macromolecule (340-400 kDa) has previously been identified in the solubilized particulate fraction of rabbit choroid plexus homogenate (Spector, 1977b) . Folate binding was of a high-affinity type (K = 1010 I/mol); it exhibited two peculiar characteristics, i.e. positive co-operativity and an affinity that increased with decreasing concentration of binder (Spector, 1979) , both of which have been described for other high-affinity folate-binding systems, e.g. in bovine milk (Hansen et al., 1978 (Hansen et al., , 1983a Salter et al., 1981) , human milk (Hansen et al., 1977 , serum , granulocytes and urine (Hansen et al., 1989a) . A folate-binding protein (FBP) from hog choroid plexus solubilized with Triton X-100 has been purified to homogeneity . Interaction ofTriton X-100 micelles with the protein was assumed to explain the large apparent molecular mass (200 kDa) ofFBP on Sephadex G-200 gel filtration as compared with that observed on SDS/PAGE (51 kDa; . A partially purified FBP from human choroid plexus (21 nmol of FBP/g of protein) seemed to be membrane-bound since it required the presence of Triton X-100 above critical micellar concentration for optimum folate binding . On SDS/ PAGE its molecular mass ranged from 45 to 60 kDa, whereas an apparent molecular mass of 200 kDa was found on Sephadex G-200 gel filtration .
We have established the presence of a high-affinity FBP in human cerebrospinal fluid . The protein was shown to cross-react with rabbit antibodies against low-molecular-mass FBP from human milk (Hansen et al., 1989b) . The present study deals with a high-affinity FBP in human choroid plexus, and describes its radioligand-binding characteristics, subcellular localization, immunological properties, molecular heterogeneity and hydrophobic domains. Because of the instability of 5-methyltetrahydropteroylglutamate, the major form of endogenous folate (O'Broin et al., 1975) , we preferred [3H]-pteroylglutamate as the radioligand.
MATERIALS AND METHODS

Tissue preparation
Human choroid plexus was homogenized with a Braun homogenizer (5 strokes at 1000 rev./min) in 5 mM-Tris/HCl buffer (pH 7.4, 4°C) containing 5 mM-mannitol (5 ml of buffer/g of tissue). Homogenate solubilized (2 h, 4°C) with Triton X-100 (20 g/l, Triton X-100/protein ratio 4.7) was centrifuged (1000 g, 30 min) and the supernatant analysed. Membrane pellets were prepared after CaCl2 precipitation (Kessler et al., 1978) . Homogenate left at 4°C for 20 min after addition of CaCl2 (10 mM) was centrifuged (1000 g, 15 min), and the pellet (A) solubilized with Triton X-100 for 2 h at 4°C (Triton X-100/protein ratio 11.4). Enzymes, 1976) .
Radioligand binding and dissociation
Tissue preparations were dialysed against 0.2 M-sodium acetate buffer (pH 3.5, 4°C) to remove endogenous folate (see below). Equilibrium-dialysis experiments were performed as described (Hansen et al., 1983a) .
Portions (1 ml ). E.l.i.s.a. for FBP in human choroid plexus Rabbit antisera against low-molecular-mass FBP from human milk (Svendsen et al., 1982; Hansen et al., 1983b) were pooled, and the immunoglobulins were precipitated and employed in an e.l.i.s.a. (H0ier-Madsen et al., 1987) .
Gel filtration
The molecular size of [3H]folate-bound FBP was estimated by chromatography in the presence of Triton X-100 (1 g/l) on a column (5.3 cm2 x 94 cm) of Ultrogel AcA 44 (IBF) . Samples were treated with or without the proteinase inhibitor, phenylmethanesulphonyl fluoride (PMSF) (1 mM; BDH).
Immunoprecipitation
The experimental procedure was similar to that of 0sterman et al. (1979) . Briefly, 200 pl of the 100 kDa FBP (see above) was mixed with 200,1 of rabbit anti-(human FBP) serum diluted with Tris buffer (pH 7.4) containing 1 g of Triton X-100/1. The mixture was incubated for 1 h at 25°C before addition of 50,1u of rabbit serum (Dako, cat. no. 902) and 1 ml of an aqueous solution of 150 g of poly(ethylene glycol) 6000 1 (Merck, cat. no. 807491). After centrifugation (2000 g, 20 min, 4 C) 500,u1 of supernatant was taken for radioactivity measurements (control experiments with the peak of free [3H]folate).
Treatment of choroid plexus B pellet with phospholipase C and phosphatidylinositol-specific phospholipase C An aqueous solution of phospholipase C (Bacillus cereus, 245 units/ml) supplied by Sigma (P 6135) was mixed (6 ,ul) with 62 ,ul of 40 mM-Hepes buffer (pH 7.4) containing BSA (2 g/1) and 1 mM-EDTA. A volume of 50 ,ul of solubilized B pellet treated with 1 mM-PMSF was added to the enzyme solution and the mixture of B pellet and enzyme (final enzyme concentration 12.5 units/ml) was left at 37°C overnight (solution B) . A parallel incubation of B pellet without enzyme (solution A) was performed. Further, to exclude the possibility that the enzyme possessed folate-binding activity, a solution of enzyme was exposed to [3H] folate and subjected to gel filtration.
Solutions of B pellet preincubation with (B) or without (A) enzyme (see above) were incubated in 700 ,ul of 0.17 M-Tris/HCI (pH 7.4) buffer containing Triton X-100 (10 g/l) and 10 nm-
[3H]folate for 1 h at 25°C before Ultrogel AcA 44 chromatography.
A similar experiment was performed with phosphatidylinositol-specific phospholipase C (B. cereus, EC 3.1.4.10) from Sigma (P8804) (3,l; 125 units/ml) using a 3 h incubation.
SDS/PAGE (Laemmli, 1970) and immunoblotting (KyhseAndersen, 1984) These were performed on fractions obtained after gel chromatography of solubilized choroid plexus homogenate concentrated 10-fold (Hansen et al., 1989b) . Rabbit anti-(human milk FBP) serum and normal rabbit serum (control) were diluted 1: 50 in phosphate-buffered saline (PBS) containing 0.05 % Tween 20. The second antibody, anti-rabbit (total) Ig, (Dako), was diluted 1:1000 in PBS. o-Dianisidine was used as the chromogen.
Immunohistochemistry
Immunohistochemistry on paraffin-embedded 5-8 ,um sections of formalin-fixed choroid plexus was performed by a standard procedure , 1984 . A commercial kit (Vector Stain ABC kit, Vector Laboratories, Burlingame, CA, U.S.A.) was used. The primary antibody [rabbit anti-(human milk FBP) serum] was diluted 1 to 8000 with 12.5 % (w/v) BSA. Parallel controls using normal rabbit serum (diluted 1:8000) were performed.
RESULTS
Mechanism of radioligand binding and dissociation in choroid plexus
Saturation curves for radioligand binding in choroid plexus homogenate at two FBP concentrations are shown in Fig. 1 (Scatchard plots inserted). Binding data analysed in Scatchard and Hill plots (not shown) are summarized in Table 1 The column was calibrated as previously described binding displayed apparent positive co-operativity as indicated by a Hill coefficient significantly higher than 1.00 and an upward convex Scatchard plot (Fig. 1) at FBP concentrations of 1.8 nm.
Vol. 280 1_P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~. ..;.. purified human milk FBP, choroid plexus homogenate, A pellet and B pellet in Fig. 2 demonstrate a particularly low immunoreactivity of FBP in the B pellet. Exposure of tissue samples to folate before analysis had no effect on immunoreactivity (results not shown). Table 2 shows the localization of FBP and y-glutamyltransferase in the choroid plexus. A parallel increase in enzyme activity/g of protein and [3H]folate binding/g of protein was seen from choroid plexus homogenate to B pellet. The modest increase in immunochemically determined FBP corresponded to a drastic fall in the relative immunoreactivity from 0.51 in choroid plexus homogenate to 0.16 in the B pellet.
Localization of FBP in choroid plexus
Gel filtration of FBP in the B pellet
As shown in Fig. 3 Effect of phospholipase C and phosphatidylinositol-specific phospholipase C on the gel-filtration profile of FBP in the B pellet After exposure to these two enzymes, peaks I and II disappeared from the gel-filtration diagram which now only contained one large peak III (25 kDa) of FBP (data obtained with phospholipase C are shown in Fig. 4) . No FBP was found in the gel-filtration profile of enzyme solutions saturated with [3H]folate (results not shown).
SDS/PAGE and immunoblotting
As shown in Fig. 5 , SDS/PAGE and immunoblotting of > 110 kDa and 25 kDa FBP (see Fig. 3 ) gave rise to identical bands (molecular masses approx. 67000).
Immunohistochemistry Fig. 6(a) shows immunostaining ofchoroid plexus cells exposed to rabbit anti-(human milk FBP) serum (1:8000 dilution). No staining reaction (Fig. 6b ) occurred with normal rabbit serum (1: 8000 dilution).
DISCUSSION
Folate binding in human choroid plexus exhibits characteristics typical of high-affinity folate-binding systems in milk, human biological fluids and granulocytes (Hansen et al., 1977 (Hansen et al., , 1978 (Hansen et al., , 1983a (Hansen et al., , 1989a Salter et al., 1981; Holm et al., 1980 Holm et al., , 1985 , for example (1) apparent positive co-operativity, which changed into a simple non-co-operative binding at relatively low FBP concentrations, (2) a binding affinity that seemed to increase with decreasing concentrations of FBP and (3) an extremely slow ligand dissociation at pH 7.4, which became rapid and complete at pH 3.5.
The highest concentration of FBP was associated with membrane preparations where the enzyme y-glutamyltransferase has its main localization (Salgo & Szabo, 1982) .
The gel-filtration profile of solubilized membrane pellet (B pellet) contained two major FBPs (> 1 10 kDa and 100 kDa) and one minor (25 kDa) FBP. Similar FBPs were found in human cerebrospinal fluid where the 25 kDa FBP, however, prevailed (Hansen et al., , 1989b . Phosphatidylinositol-specific phospholipase C decreased the apparent molecular size of the > 110 and 100 kDa FBPs to 25 kDa in the presence of the proteinase inhibitors PMSF and EDTA; apart from being a proteinase inhibitor, EDTA inhibits phosphatidylcholine-specific but not phosphatidylinositol-specific phospholipase C (Ikezawa & Taguchi, 1981 ). An enzyme-induced cleavage ofa hydrophobic glycosylphosphatidylinositol moiety that inserts FBP into Triton X-100 micelles could account for this phenomenon as well as the identical molecular masses of > 110 kDa and 25 kDa FBPs on SDS/PAGE immunoblotting. By analogy, membrane and soluble forms of FBP from human KB cells were similar with respect to amino acid composition, N-terminal amino acid sequence and molecular mass on SDS/PAGE, but differed in that membrane FBP contained a glycosylphosphatidylinositol membrane anchor (Luhrs et al., 1986 (Luhrs et al., , 1987 Luhrs & Slomiany, 1989) , which explained its apparently larger molecular mass on gel filtration, and its release from membranes by phosphatidylinositol-specific phospholipase C (Luhrs & Slomiany, 1989) . Likewise, membrane FBP could be released from its glycosylphosphatidylinositol membrane anchor on human CaCo-2 cells (Lacey et al., 1989) .
By analogy with FBP in erythrocyte membranes (Antony et al., 1987a,b) , the variation in relative immunoreactivity (Fig. 2 and (Kamen & Capdevila, 1986) . In contrast, surface-bound folate could be released by incubation of the cells at pH 3.5 (Kamen & Capdevila, 1986) . The low relative immunoreactivity ( Fig. 2 and Table 2 ) of FBP localized in choroid plexus membranes is thus in fair agreement with the latter theory.
